Brief: PLx Pharma Says On Track For Vazalore Regulatory Pathway
June 19 (Reuters) - PLx Pharma Inc PLXP.O :
* PLX PHARMA ON TRACK FOR VAZALORE REGULATORY PATHWAY
* PLX PHARMA INC - RECENTLY CONDUCTED A TYPE C MEETING WITH
U.S.
FOOD AND DRUG ADMINISTRATION REGARDING APRIL BRIEFING PACKAGE
SUBMISSION FOR VAZALORE
* PLX PHARMA INC - REMAINS ON TRACK TO FILE FOR APPROVAL BY
YEAR-END, AS PLANNED
* PLX PHARMA INC - CURRENTLY MANUFACTURING REGISTRATION
BATCHES
THAT WILL PROVIDE DATA TO MEET THIS REGULATORY MILESTONE.
Source text for Eikon: ID:nGNX3v5WGL
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice